Interestingly, SCUBE2 has been associated with ER/PR positive tumors 35 and proposed as a tumor suppressor in breast cancer,36 yet it has also been shown as the only common gene in outcome‐predictive signature assays in breast cancer.37 This evidence concerns the gene ESR1 and breast cancer.